- Home
- RIGL vs CZFS Comparison
RIGL vs CZFS Comparison
Compare RIGL & CZFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- CZFS
- Stock Information
- Founded
- RIGL 1996
- CZFS 1984
- Country
- RIGL United States
- CZFS United States
- Employees
- RIGL N/A
- CZFS N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- CZFS Major Banks
- Sector
- RIGL Health Care
- CZFS Finance
- Exchange
- RIGL Nasdaq
- CZFS Nasdaq
- Market Cap
- RIGL 335.5M
- CZFS 291.1M
- IPO Year
- RIGL 2000
- CZFS N/A
- Fundamental
- Price
- RIGL $20.97
- CZFS $59.05
- Analyst Decision
- RIGL Buy
- CZFS
- Analyst Count
- RIGL 5
- CZFS 0
- Target Price
- RIGL $36.40
- CZFS N/A
- AVG Volume (30 Days)
- RIGL 217.1K
- CZFS 7.9K
- Earning Date
- RIGL 08-05-2025
- CZFS 07-29-2025
- Dividend Yield
- RIGL N/A
- CZFS 3.28%
- EPS Growth
- RIGL N/A
- CZFS 53.00
- EPS
- RIGL 2.08
- CZFS 5.97
- Revenue
- RIGL $203,077,000.00
- CZFS $99,929,000.00
- Revenue This Year
- RIGL $14.41
- CZFS N/A
- Revenue Next Year
- RIGL $15.97
- CZFS $5.45
- P/E Ratio
- RIGL $10.14
- CZFS $10.01
- Revenue Growth
- RIGL 70.16
- CZFS 9.54
- 52 Week Low
- RIGL $7.48
- CZFS $39.10
- 52 Week High
- RIGL $29.82
- CZFS $75.40
- Technical
- Relative Strength Index (RSI)
- RIGL 61.71
- CZFS 48.20
- Support Level
- RIGL $18.63
- CZFS $58.33
- Resistance Level
- RIGL $20.99
- CZFS $64.00
- Average True Range (ATR)
- RIGL 1.07
- CZFS 2.10
- MACD
- RIGL 0.11
- CZFS -0.36
- Stochastic Oscillator
- RIGL 82.81
- CZFS 11.13
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.